Kaia Health offers AI-assisted digital therapies via a mobile app for chronic musculoskeletal (MSK) pain and COPD, using computer vision for real-time posture tracking and feedback without wearables. The app covers neck, hip, knee, shoulder, hand/wrist and foot/ankle pain and uses motion-tracking both to correct exercises and as an objective biomarker of physical function. Kaia’s platform is accessible to 60M patients and it serves around 50 employer and health-plan clients; U.S. activation rates range from ~5–10%. The company grew its business book 600% in 2020 and expects 5x–10x revenue growth in the coming 12 months as larger partnerships onboard. Kaia is investing in building out its commercial team and expanding its computer-vision capabilities, and is integrating its app into wider care pathways with referral and triage systems. In Europe it is pursuing prescription/reimbursement routes (notably Germany) and is launching a COPD app with a pharma partner. Kaia Health develops smartphone camera–based digital therapeutics using computer vision for real-time posture tracking to deliver hands‑free physiotherapy. It offers multimodal “mind body therapy” apps for musculoskeletal disorders, currently for chronic back pain and a pulmonary rehabilitation program for COPD, and is set to launch a knee and hip osteoarthritis app soon. Kaia retired an earlier direct-to-consumer subscription strand to focus on B2B sales to self‑insured employers and health payers, with the goal of obtaining reimbursement as a medical claim. The company reports roughly 400,000 users across its apps and says its market mix has flipped from predominantly Europe to predominantly the US. Kaia emphasizes clinical validation — it published a randomized controlled trial in Nature and currently has nine clinical studies ongoing with more publications expected. Planned product and research work includes building its US commercial team, funding additional clinical studies, and R&D to extend posture modelling toward 3D tracking on standard smartphones without depth sensors. Kaia Health is a New York City-based digital therapeutics company that develops smartphone-based treatments for a range of chronic disorders, with a leading product focused on musculoskeletal (MSK) conditions such as chronic back pain. The platform uses 2D motion-tracking via the smartphone camera to provide real-time feedback on exercise performance, combined with psychological and educational support. Led by founder and CEO Konstantin Mehl, Kaia has enrolled more than 275,000 users to date in its digital therapy program. On 17 September 2019 the company raised $8M in funding led by Optum Ventures. Kaia intends to use the proceeds to accelerate sales growth in the U.S. healthcare market, extend the platform into additional chronic indications and expand the supporting clinical evidence base. Kaia Health offers an app-based, multimodal “mind-body” therapy for musculoskeletal (MSK) disorders that combines guided physical exercises, psychological techniques and medical education. The product uses computer-vision via a smartphone camera to act as a fully autonomous exercise coach, tracking body positions and giving vocal feedback to correct posture and motion. Kaia targets chronic back pain as its first focus and positions the app as a scalable, lower-cost alternative to one-on-one physiotherapy and opioid-based treatments. The company reports around 250,000 users via both a B2C offering and distribution through organizations and insurers in Europe and the U.S., with current usage roughly 80% Europe and 20% U.S. Future plans include scaling up in the U.S. (including a new New York City office), expanding the platform to other conditions, and funding longer clinical studies and pending peer-reviewed randomized controlled trial publication. The startup raised a $10M Series A to support these growth and clinical-research efforts.

Total raised

$119M

Funding rounds

4

Latest round

Series C

Latest activity

Apr 2021